Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Hist Psychol ; 24(2): 130-135, 2021 05.
Article in English | MEDLINE | ID: mdl-34081518

ABSTRACT

In this article, I present some of the most interesting attempts to go beyond the natural kinds approach to emotions, paying special attention to the work of Fay Bound Alberti and Rob Boddice, both of whom have been influenced by Lisa Feldman Barrett's theory of constructed emotions. I propose that some of the flaws detected in the history of the emotions by Bound Alberti and Boddice can be solved relying on social psychology, and specifically I propose Larissa Z. Tiedens and Colin W. Leach's (2004) The Social Life of Emotions as a useful approach. In conjunction with Barrett's theory, Tiedens and Leach provide a framework in which history of the emotions can harness its full potential, encompassing a more comprehensive approach to emotional experience. I discuss the idea of a new history of emotional experiences and suggest some of its possible features. I make a plea for a collaborative, transdisciplinary approach to the study of the emotions, in which humanities and social sciences play a fundamental role. (PsycInfo Database Record (c) 2021 APA, all rights reserved).

2.
Am J Ther ; 18(2): 92-100, 2011.
Article in English | MEDLINE | ID: mdl-20027110

ABSTRACT

Primary percutaneous coronary intervention (PCI) of culprit lesions (CLs) is the standard of care in patients presenting with ST elevation myocardial infarction (STEMI). However, optimal revascularization strategy for significant nonculprit lesions (non-CLs) in the setting of STEMI remains controversial. The importance of defining of such a strategy lies in the fact that approximately 50% of patients with STEMI have multivessel disease (MVD). The aim of this study was to describe characteristics, therapeutic strategies, and 1-year outcomes in a cohort of patients with STEMI and MVD. We retrospectively analyzed a cohort of 63 patients with STEMI and MVD obtained from a 5-year catheterization database. MVD was defined as ≥70% stenosis of ≥2 epicardial coronary arteries. This cohort was followed for a period of 1 year for major adverse cardiac events (MACE was defined as acute coronary syndrome, new onset heart failure, or death) and all-cause mortality. PCI with stent placement was the major therapeutic procedure (87.5%) performed for CLs. Non-CLs did not undergo interventions in a majority of individuals (47.6%), while the remaining patients underwent PCI (29%) and coronary artery bypass graft surgery (22%) for non-CLs. At 1-year follow-up, prevalence of MACE events and death in the entire cohort were 30% and 15%, respectively. A trend for better outcomes (1-year cumulative MACE events but not mortality) was observed in CL-only intervention cohort compared with non-CL intervention. The PCI and Coronary artery bypass graft surgery cohorts did not show any significant difference in clinical outcomes. In this retrospective cohort of patients with MVD who presented with STEMI, no intervention of noncritical lesions was the prevalent approach, reflecting guideline recommendations. CL-only intervention strategy showed a better clinical outcome than non-CL intervention. Intervention of noncritical lesions therefore did not seem to improve MACEs or all-cause mortality at 1-year of follow-up and might in fact have had a detrimental effect on outcomes.


Subject(s)
Angioplasty, Balloon, Coronary/methods , Coronary Artery Bypass/methods , Coronary Stenosis/therapy , Myocardial Infarction/therapy , Adult , Aged , Aged, 80 and over , Cohort Studies , Coronary Stenosis/epidemiology , Coronary Stenosis/physiopathology , Databases as Topic , Female , Follow-Up Studies , Humans , Male , Middle Aged , Myocardial Infarction/physiopathology , Myocardial Infarction/surgery , Practice Guidelines as Topic , Retrospective Studies , Stents , Treatment Outcome
3.
Cardiovasc Hematol Agents Med Chem ; 7(3): 181-92, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19689256

ABSTRACT

The no-reflow phenomenon is a poorly understood complication of percutaneous coronary intervention in which diminished blood flow to distal microvascular beds persists despite the successful treatment of the occlusive lesion from the epicardial coronary artery or arteries. In this contemporary review we endeavour to discuss the pathophysiology of coronary no-reflow, understand the predictors and describe current pharmacological and mechanical strategies to prevent and treat coronary no-reflow.


Subject(s)
Coronary Circulation , No-Reflow Phenomenon/drug therapy , No-Reflow Phenomenon/physiopathology , Adenosine/therapeutic use , Animals , Diltiazem/therapeutic use , Humans , Nicardipine/therapeutic use , Nicorandil/therapeutic use , Nitroprusside/therapeutic use , No-Reflow Phenomenon/therapy , Prostheses and Implants , Vasodilator Agents/therapeutic use , Verapamil/therapeutic use
4.
Can J Cardiol ; 23(14): 1155-6, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18060102

ABSTRACT

Pericardiocentesis for therapeutic drainage of pericardial fluid may be associated with a variety of complications, including laceration of the right ventricle or coronary artery, arrhythmias, viscus perforation, hypotension, pneumothorax, adult respiratory distress syndrome and death. Hemodynamic derangements such as acute left ventricular failure, pulmonary edema and cardiogenic shock are infrequent and, hence, less well recognized. The present report describes a patient with pericardial effusion and tamponade who developed cardiogenic shock requiring inotropic support shortly following uncomplicated ultrasound-guided pericardial drainage.


Subject(s)
Cardiac Tamponade/surgery , Pericardiocentesis/adverse effects , Pulmonary Edema/etiology , Acute Disease , Cardiac Tamponade/diagnosis , Diagnosis, Differential , Echocardiography , Electrocardiography , Female , Follow-Up Studies , Humans , Magnetic Resonance Imaging , Middle Aged , Pulmonary Edema/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...